PhiTech Bioinformatics focuses on advancing the integration of various omics technologies into clinical settings to enhance disease understanding and diagnostics. Their offerings include comprehensive genomic analyses through Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), and targeted sequencing. Additionally, they provide transcriptomic services that analyze RNA-Seq data to identify gene expression levels, splicing variations, and genetic variants. The company also delves into epigenomics, utilizing ChIP-Seq and Methyl-Seq data to explore genetic and epigenetic regulatory mechanisms, as well as microbiomics, which characterizes microbiota by identifying prevalent microbial species and their phenotypic associations.

Beyond traditional genomics, PhiTech employs advanced algorithms to extract critical information for diagnostic decision-making, thereby enhancing the utility of bioinformatics in healthcare. Their commitment to merging life sciences with computer sciences aims to deliver state-of-the-art technological solutions that benefit humanity. PhiTech offers end-to-end bioinformatics solutions tailored for researchers in life and environmental sciences, emphasizing the integration of transcriptomics and genomics to develop innovative diagnostic technologies.

Turkey

PhiTech Bioinformatics translates genome-wide molecular data (Genomics, Transcriptomics, Epigenomics, Microbiomics, etc.) into biotechnology solutions primarily for use in precision medicine.  

We are moving beyond genomics by applying cutting-edge algorithms to extract information critical for diagnostic decision making. We are currently focusing on development of RNA-based diagnostics.

Follow us on Twitter @PhiTech_Bioinfo

PhiTech Bioinformatics

Company Details